The global biotechnology company announced the launch of GENE-UP PROBIOTIC SPECIES ID, a commercialized species-level ...
The hepatitis testing market presents significant opportunities driven by rising hepatitis infections, increasing demand for early diagnosis, and advancements in rapid point-of-care testing. Key ...
A cluster-randomized clinical trial finds that adoption of onsite polymerase chain reaction (PCR) testing for COVID-19, ...
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are a significant cause of morbidity and ...
Visby Medical’s over the counter (OTC) combination PCR test for Covid-19 and influenza A/B detection has secured US Food and ...
Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug Administration (FDA) clearance for the ...
The race to produce a rapid antigen test to diagnose the rare Bundibugyo Ebola virus ‌has closed in on five possible manufacturers that could begin field trials in eastern Congo within weeks, a global ...
New Roche test targeting detection of Bundibugyo virus supports efforts to address critical need during ongoing outbreaks 1 Roche's unique outbreak response capabilities enabled rapid development of ...
Six years after the COVID pandemic began, we are still locked in three of the five stages of a so-called typical response to a pandemic, as described in a recent opinion article. Those three stages ...
The MarketWatch News Department was not involved in the creation of this content. DURHAM, N.C., March 31, 2026 /PRNewswire/ -- Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the ...
Harlem Hospital ignored its own commitment to conduct weekly rapid testing that could have prevented the spread of Legionnaires' disease ahead of last summer’s deadly outbreak, according to documents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results